|
| Status |
Public on Jan 30, 2012 |
| Title |
Patient P2 @Week 12 |
| Sample type |
RNA |
| |
|
| Source name |
Patient P2 @Week 12
|
| Organism |
Homo sapiens |
| Characteristics |
patient: P2
group: Week 12
tissue: skin
treatment: efalizumab
disease state: psoriasis
time: week 12
disease status: non-relapse
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Whole skin punch biopsies were homogenized in RLT with Beta-2-mercaptoethanol, RNA was extracted using RNeasy-Micro kit (QIAGEN, Valencia, CA).
|
| Label |
biotin
|
| Label protocol |
GeneChip Two-Cycle cDNA Synthesis Kit (Affymetrix )
|
| |
|
| Hybridization protocol |
GeneChip Two-Cycle cDNA Synthesis Kit (Affymetrix )
|
| Scan protocol |
Hewlett-Packard GeneArray Scanner G25Time: 0Time: 0A.
|
| Data processing |
GCRMA (using gcrma package from R/Bioconductor)
|
| |
|
| Submission date |
Jul 19, 2011 |
| Last update date |
Apr 04, 2012 |
| Contact name |
Mayte Suarez-Farinas |
| E-mail(s) |
mayte.suarezfarinas@mssm.edu
|
| Organization name |
Mount SinaiSchool of Medicine
|
| Street address |
1425 Madison Ave, L2-70C, Box 1077,
|
| City |
New York |
| State/province |
NY |
| ZIP/Postal code |
10075 |
| Country |
USA |
| |
|
| Platform ID |
GPL571 |
| Series (1) |
| GSE30768 |
Post-therapeutic relapse of psoriasis associated with CD11a blockade is associated with T cells and inflammatory myeloid DCs |
|
